Increased progerin expression associated with unusual LMNA mutations causes severe progeroid syndromes

Area of Science:

• Genetics and Molecular Biology
• Cell Biology
• Rare Diseases

Background:

• Hutchinson-Gilford progeria syndrome (HGPS) is a rare genetic disorder characterized by premature aging.
• It is typically caused by mutations in the LMNA gene, leading to the production of a toxic protein called progerin.
• Progerin accumulation results in nuclear abnormalities and severe clinical manifestations.

Observation:

• Two patients presented with unusually severe HGPS phenotypes.
• Genetic analysis revealed novel LMNA mutations: a splice site mutation (c.1968+1G>A) and a synonymous coding mutation (c.1821G>A).
• These mutations led to increased utilization of the exon 11 splice donor site, resulting in higher progerin mRNA and protein levels compared to typical HGPS.

Findings:

• Both patients exhibited characteristic nuclear shape abnormalities in fibroblasts.
• Cells from these patients showed a significant reduction in misshapen nuclei upon treatment with a protein farnesyltransferase inhibitor.
• The study identified higher progerin expression levels in these severe HGPS cases.

Implications:

• The findings suggest that protein farnesyltransferase inhibitors may be effective even in severe HGPS cases with elevated progerin levels.
• This research expands the understanding of LMNA mutations and their impact on HGPS.
• It offers potential therapeutic avenues for patients with severe forms of this rare aging syndrome.